{
    "2019-07-31": [
        [
            {
                "time": "2019-07-31",
                "original_text": "格隆汇个股放量排行版 | 7月31日",
                "features": {
                    "keywords": [
                        "个股",
                        "放量",
                        "排行"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07",
                "original_text": "2019年7月份，多家制药企业获得药品GMP证书",
                "features": {
                    "keywords": [
                        "制药企业",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07",
                "original_text": "医药产业迎来发展大变革，药企纷纷走上创新之路",
                "features": {
                    "keywords": [
                        "医药产业",
                        "发展变革",
                        "创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019",
                "original_text": "伏明霞老公接手“和睦家” 复星医药拟5.23亿美元出售",
                "features": {
                    "keywords": [
                        "复星医药",
                        "和睦家",
                        "出售"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019",
                "original_text": "新风天域将收购和睦家医疗，成为中国最大的上市综合私立医疗机构之一",
                "features": {
                    "keywords": [
                        "新风天域",
                        "和睦家",
                        "收购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019",
                "original_text": "复星医药(02196-HK)售和睦家医院和诊所权益料收益16.5亿人民币",
                "features": {
                    "keywords": [
                        "复星医药",
                        "和睦家",
                        "收益"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019",
                "original_text": "费用激增、财务爆雷丨一场药企、医院和管理者间的抢位战",
                "features": {
                    "keywords": [
                        "费用激增",
                        "财务爆雷",
                        "药企",
                        "医院"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}